News for 'drug quality'

Clean chit for J&J's baby shampoo

Clean chit for J&J's baby shampoo

Rediff.com10 Jun 2019

The outcome reaffirms the company's own testing and the long-standing assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, J&J said.

PM may announce these health sector initiatives in I-Day speech

PM may announce these health sector initiatives in I-Day speech

Rediff.com14 Aug 2022

Prime Minister Narendra Modi is likely to announce a host of initiatives for the health sector on Independence Day with the highlights being the 'Heal in India' and 'Heal by India' projects and a roadmap to eliminate sickle cell disease by 2047, official sources said.

How to Take Care of your Liver

How to Take Care of your Liver

Rediff.com20 Apr 2021

Dr Anurag Shrimal tells you how simple lifestyle changes can keep your liver healthy.

For India's cannabis industry the grass could be greener

For India's cannabis industry the grass could be greener

Rediff.com9 Mar 2021

'The government wants farmers to diversify from rice and wheat, and create another green revolution. Cannabis can play a big part in that'

WHO to decide next week on approval to Covaxin

WHO to decide next week on approval to Covaxin

Rediff.com5 Oct 2021

'WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin,' the global health body tweeted.

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

Rediff.com10 Jan 2023

This doctor couple put their faith in India. And in return India has put faith in them.

Waves of global protectionism may nix 'Make in India' dream

Waves of global protectionism may nix 'Make in India' dream

Rediff.com30 Mar 2017

Saudi Arabia is insisting on 'In Kingdom' total value-addition requirements

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

Novartis buys GSK's cancer drugs for $16 bn in three-part deal

Novartis buys GSK's cancer drugs for $16 bn in three-part deal

Rediff.com22 Apr 2014

In separate statements, the two companies said they will combine Novartis' over-the-counter division with GSK's consumer business, creating a new world-leading consumer healthcare business with $10 billion in annual sales.

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Rediff.com19 Aug 2020

Reliance Retail Ventures Ltd has acquired a majority equity stake in digital pharma market place Netmeds for a cash consideration of around Rs 620 crore, Reliance Industries said in a late night statement on Tuesday.

Indian-American teen wins $25K for work on potential COVID-19 treatment

Indian-American teen wins $25K for work on potential COVID-19 treatment

Rediff.com19 Oct 2020

Chebrolu said she was inspired to find potential cures to viruses after learning about the 1918 flu pandemic and finding out how many people die every year in the US despite annual vaccinations and anti-influenza drugs on the market.

Smarting under statement withdrawal, Ramdev poses 25 questions to IMA

Smarting under statement withdrawal, Ramdev poses 25 questions to IMA

Rediff.com25 May 2021

In an 'open letter' posted on his Twitter handle, Ramdev posed 25 questions to IMA, which had objected to his video clip running down allopathy treatment for COVID-19.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Pharma cos should learn to appreciate FDA norms: Experts

Pharma cos should learn to appreciate FDA norms: Experts

Rediff.com23 Nov 2014

Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations

30 groups in India trying to develop COVID-19 vaccine: PSA

30 groups in India trying to develop COVID-19 vaccine: PSA

Rediff.com28 May 2020

Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.

Naxalism with guns or pens must be uprooted: Modi tells state home ministers

Naxalism with guns or pens must be uprooted: Modi tells state home ministers

Rediff.com28 Oct 2022

Prime Minister Narendra Modi on Friday mooted the idea of "One Nation, One Uniform" for the police, saying it is just a suggestion for consideration and he is not trying to impose it on the states.

How Covid took devastating turn in 2021

How Covid took devastating turn in 2021

Rediff.com29 Dec 2021

A second wave of Covid driven by the Delta variant engulfed the country in May-June bringing the health system to its knees and leaving people gasping for help.

Problems related to bones, muscles persist post Covid

Problems related to bones, muscles persist post Covid

Rediff.com12 Oct 2021

The systemic inflammatory response to SARS-CoV-2 adversely impacts the musculoskeletal system. Inflammatory molecules break the muscle fiber protein and decrease muscle protein synthesis leading to decreased muscle strength and also weaken bones.

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

Rediff.com17 Sep 2021

India's top vaccinologist Gagandeep Kang stressed the need to develop better vaccines that can deal with new variants, and strengthening of the regulatory mechanisms.

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rediff.com5 Apr 2022

According to sources close to ANI, "Bharat Biotech has informed Union health ministry that it will rectify the issues pointed out by WHO in 15 to 20 days." "World Health Organisation (WHO)'s suspension is not related to safety or efficacy issues but limited only to supply for United Nations agencies."

Engaged with US entities for procurement of vaccines: MEA

Engaged with US entities for procurement of vaccines: MEA

Rediff.com20 May 2021

India is engaged with American entities for procurement of COVID-19 vaccines from the United States and their possible manufacturing in the country subsequently, the Ministry of External Affairs said on Thursday.

Dr V Shanta, renowned cancer specialist, passes away

Dr V Shanta, renowned cancer specialist, passes away

Rediff.com19 Jan 2021

Renowned oncologist and chairperson of the Cancer Institute in Chennai, Dr V Shanta, who is noted for her outstanding contribution to cancer care, died early on Tuesday. She was 93.

Why Is Mohammed Zubair In Jail?

Why Is Mohammed Zubair In Jail?

Rediff.com4 Jul 2022

This is New India, where our heroes and heroines are vilified and jailed by a State intent on damaging its own people, asserts Aakar Patel.

Qualities that will help a leader tide over crisis

Qualities that will help a leader tide over crisis

Rediff.com7 Apr 2014

During a crisis situation, effective communication both internally and externally is one of the most important measures.

DCGI approves commercial launch of low-cost Covid test 'Feluda'

DCGI approves commercial launch of low-cost Covid test 'Feluda'

Rediff.com20 Sep 2020

This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.

Kejriwal's Dalit pitch in Punjab: Remember Ambedkar while voting

Kejriwal's Dalit pitch in Punjab: Remember Ambedkar while voting

Rediff.com28 Jan 2022

In an apparent bid to reach out to Dalit voters, Aam Aadmi Party national convener Arvind Kejriwal on Friday urged people to remember Dr Bhim Rao Ambedkar while voting in next month's assembly polls and said he "worships" the leader.

'Maligning the medical fraternity was not expected of PM'

'Maligning the medical fraternity was not expected of PM'

Rediff.com22 Apr 2018

The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.

Ankylosing Spondylitis: The back pain that should alarm young India

Ankylosing Spondylitis: The back pain that should alarm young India

Rediff.com8 Jan 2018

Nearly 30 to 40 lakh people in India suffer from Ankylosing Spondylitis.

Vaccine production can't be ramped up overnight: Govt

Vaccine production can't be ramped up overnight: Govt

Rediff.com29 May 2021

"The concrete actions are a stern indication that Government of India is making all out efforts to increase vaccine production in the country as well as attracting foreign vaccine manufacturers to supply the required vaccine doses for national Covid vaccination programme," the ministry in a statement.

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

What Will Modi's Scientific Advisor Do?

What Will Modi's Scientific Advisor Do?

Rediff.com13 May 2022

Dr Ajay Kumar Sood will have to complete a task his predecessor started: Getting the government to sign off on a new Science, Technology, and Innovation Policy on which work was begun in 2020.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Rediff.com24 May 2021

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in India, according to a joint statement issued.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

Delta plus: New Covid variant identified in India

Delta plus: New Covid variant identified in India

Rediff.com14 Jun 2021

The highly transmissible Delta variant of SARS-CoV-2 has mutated further to form the 'Delta plus' or 'AY.1' variant but there is no immediate cause for concern in India as its incidence in the country is still low, scientists in New Delhi said.

India's COVID-19 fatality rate slides to 1.76%: Govt

India's COVID-19 fatality rate slides to 1.76%: Govt

Rediff.com2 Sep 2020

As many as 1,578 dedicated COVID hospitals are providing quality medical care.